CATALYST clinical trial : FDA approves Abbott’s trial of Amplatzer Amulet device in AF

pharmanewsdaily- February 4, 2020 0

Abbott has been granted approval from the US Food and Drug Administration (FDA) for the CATALYST clinical trial to assess its Amplatzer Amulet Left Atrial ... Read More